Key result
Disrupting neural crest valve endocardial cells or Pthlh causes valve stenosis, regurgitation, and perinatal lethality.
Why the study?
Abnormalities in cardiac valves are the most common form of structural heart disease, affecting 2-3% of people worldwide, yet the specific cell types that compose the valve and how they communicate to direct development and homeostasis remain poorly understood.
Identifies a previously unrecognized population of neural crest-derived endocardial cells and a Pthlh signaling pathway essential for heart valve morphogenesis, offering new insights into the pathogenesis of human structural valve defects.
Answers are grounded in this paper and cite their sources.
These cells do not alter valve disease management; leaves open their role in human valvulopathies and therapeutic targeting.
Abnormalities in cardiac valves, which maintain unidirectional blood flow through the heart, affect 2-3% of people worldwide and are the most common form of structural heart disease (1).Yet the cell types that make up the valve, and how they communicate to direct development and homeostasis, remain poorly understood. Here, we identify a rare, essential population of highly secretory valve endocardial cells in mouse and human that derive from migrating neural crest cells. Ablation of these cells in mice caused perinatal lethality with thickened leaflets, stenosis, and regurgitation, mirroring human valve disease. This subset of endocardial cells uniquely expresses the secreted signaling protein parathyroid hormone-like hormone (Pthlh). Global disruption of Pthlh caused valve stenosis and lethality and neural crest-specific deletion produced similar valve disease, with impaired maturation of valvular interstitial cells and disrupted bone morphogenetic protein signaling. These findings identify a previously unrecognized cell type and signaling pathway essential for valve morphogenesis, with implications for the pathogenesis and treatment of human valve defects.
No takes yet. Share an insight, caveat, or question.
Merriman et al. (2026) studied Cardiac valve development and disease (valve stenosis and regurgitation). Ablation of neural crest-derived endocardial cells and global or neural crest-specific deletion of Pthlh was evaluated on Valve morphogenesis, stenosis, regurgitation, and perinatal lethality. Ablation of neural crest-derived valve endocardial cells or deletion of Pthlh in mice caused perinatal lethality, thickened leaflets, valve stenosis, and regurgitation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: